Correlation
The correlation between MOH and CPRX is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
MOH vs. CPRX
Compare and contrast key facts about Molina Healthcare, Inc. (MOH) and Catalyst Pharmaceuticals, Inc. (CPRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MOH or CPRX.
Performance
MOH vs. CPRX - Performance Comparison
Loading data...
Key characteristics
MOH:
-0.08
CPRX:
1.36
MOH:
0.04
CPRX:
2.16
MOH:
1.01
CPRX:
1.25
MOH:
-0.23
CPRX:
1.90
MOH:
-0.68
CPRX:
7.62
MOH:
12.55%
CPRX:
7.20%
MOH:
45.31%
CPRX:
40.96%
MOH:
-68.37%
CPRX:
-94.25%
MOH:
-27.57%
CPRX:
-4.51%
Fundamentals
MOH:
$16.68B
CPRX:
$3.03B
MOH:
$20.28
CPRX:
$1.55
MOH:
14.86
CPRX:
15.83
MOH:
-0.62
CPRX:
0.00
MOH:
0.41
CPRX:
5.67
MOH:
3.79
CPRX:
3.81
MOH:
$41.85B
CPRX:
$534.65M
MOH:
$4.78B
CPRX:
$441.72M
MOH:
$1.90B
CPRX:
$250.28M
Returns By Period
In the year-to-date period, MOH achieves a 4.40% return, which is significantly lower than CPRX's 17.78% return. Over the past 10 years, MOH has underperformed CPRX with an annualized return of 15.44%, while CPRX has yielded a comparatively higher 19.70% annualized return.
MOH
4.40%
-4.99%
2.45%
-3.53%
-0.13%
10.34%
15.44%
CPRX
17.78%
1.24%
10.03%
54.79%
49.68%
41.65%
19.70%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MOH vs. CPRX — Risk-Adjusted Performance Rank
MOH
CPRX
MOH vs. CPRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MOH vs. CPRX - Dividend Comparison
Neither MOH nor CPRX has paid dividends to shareholders.
Drawdowns
MOH vs. CPRX - Drawdown Comparison
The maximum MOH drawdown since its inception was -68.37%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for MOH and CPRX.
Loading data...
Volatility
MOH vs. CPRX - Volatility Comparison
Molina Healthcare, Inc. (MOH) has a higher volatility of 10.59% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 9.21%. This indicates that MOH's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MOH vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Molina Healthcare, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MOH vs. CPRX - Profitability Comparison
MOH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a gross profit of 1.28B and revenue of 11.15B. Therefore, the gross margin over that period was 11.5%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.
MOH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported an operating income of 433.00M and revenue of 11.15B, resulting in an operating margin of 3.9%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.
MOH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a net income of 298.00M and revenue of 11.15B, resulting in a net margin of 2.7%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.